Cogent Biosciences

COGTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.243 B

$42.39 +1.41%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$328.9M

Loss-making

Shares outstanding

170,868,004

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#45Rhythm PharmaceuticalsRYTM$7.96B
#46Tg TherapeuticsTGTX$7.62B
#47Cogent BiosciencesCOGT$7.24B
#48Mirum PharmaceuticalsMIRM$6.54B
#49Belite BioBLTE$6.41B

Where these numbers come from

Share counts and financials for Cogent Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.